Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Brivaracetam in Healthy Chinese Adults
NCT04882540Phase 1Completed
- Sponsor
- UCB
- Start
- May 2021
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of brivaracetam in epilepsy, sponsored by UCB. Primary endpoints: Plasma Concentration of BRV and Its Metabolites After Single Dose at Day 1, Plasma Concentration of BRV and Its Metabolites After Multiple Dose at Day 10 and 5 more. Started May 2021; status: completed.
02
Drugs
brivaracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT04882540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882540.